TILDIEM Side Effects

5357691-0 | Anaemia, Melaena, Rectal Haemorrhage
on Jun 11, 2007 Male patient from FRANCE , 70 years of age, was diagnosed with arteriosclerosis coronary artery and was treated with Tildiem (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, melaena, rectal haemorrhage. Tildiem dosage: . During the same period patient was treated with CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ). Patient was hospitalized.

5301579-8 | Arthralgia, Depression, Dyspepsia, Fatigue, Hyperhidrosis, Memory Impairment, Myalgia, Nausea
Patient was taking Tildiem (View Usage). Patient had the following side effects: arthralgia, depression (What is depression?), dyspepsia, fatigue, hyperhidrosis, memory impairment, myalgia, nausea (What is nausea?) on Mar 27, 2007 from NETHERLANDS Additional patient health information: Female patient , 56 years of age, was diagnosed with hypertension, hypercholesterolaemia and. Tildiem dosage: 200 Mg Qd Po. During the same period patient was treated with SELOKEN ZOC/ASA (100 Mg Qd Po) (View Seloken Zoc/asa Review and Seloken Zoc/asa Label ), ZOCOR (20 Mg Qd Po) (View Zocor Review and Zocor Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CRESTOR (View Crestor Review and Crestor Label ), PARIET (View Pariet Review and Pariet Label ), LERDIP (View Lerdip Review and Lerdip Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ).

5295516-2 | Cytomegalovirus Infection, Epstein-barr Virus Infection, Face Oedema, Herpes Virus Infection, Parvovirus Infection, Perivascular Dermatitis, Rash Maculo-papular, Skin Exfoliation
Adverse event was reported on Mar 22, 2007 by a Female patient taking Tildiem (View Usage) (Dosage: 60 Mg Qd Po) was diagnosed with lung abscess and. Location: FRANCE , 60 years of age, After Tildiem was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), epstein-barr virus infection, face oedema, herpes virus infection, parvovirus infection, perivascular dermatitis, rash maculo-papular, skin exfoliation. During the same period patient was treated with CLAVENTIN (1000 Mg Tid Iv) (View Claventin Review and Claventin Label ), FLAGYL /00012501/ (View Flagyl /00012501/ Review and Flagyl /00012501/ Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), NOVOMIX /01475801/ (View Novomix /01475801/ Review and Novomix /01475801/ Label ). Patient was hospitalized.

5278396-0 | Eczema, Rash Erythematous, Rash Macular
on Mar 06, 2007 Male patient from FRANCE , 77 years of age, was diagnosed with essential hypertension, oedema, oesophagitis, parkinson's disease (What is parkinson's disease?) and was treated with Tildiem (View Usage). Patient experienced the following unwanted or unexpected effects: eczema (What is eczema?), rash erythematous, rash macular. Tildiem dosage: 60 Mg Bid Po. During the same period patient was treated with LASIX (1 G Q Day Iv) (View Lasix Review and Lasix Label ), ELISOR (20 Mg Q Day Po) (View Elisor Review and Elisor Label ), OMEPRAZOLE (40 Mg Q Day Iv) (View Omeprazole Review and Omeprazole Label ), MADOPAR (62.5 Mg Tid Po) (View Madopar Review and Madopar Label ). Patient was hospitalized.


5271134-7 | C-reactive Protein Increased, Complement Factor Increased, Cytomegalovirus Antibody Positive, Epstein-barr Virus Antibody Positive, Face Oedema, Herpes Simplex Serology Positive, Neutrophil Count Increased, Parvovirus B19 Serology Positive, Perivascular Dermatitis
on Feb 27, 2007 Female patient from FRANCE , 60 years of age, was diagnosed with abscess (What is abscess?) and was treated with Tildiem (View Usage). Patient had the following side effects: c-reactive protein increased, complement factor increased, cytomegalovirus antibody positive, epstein-barr virus antibody positive, face oedema, herpes simplex serology positive, neutrophil count increased, parvovirus b19 serology positive, perivascular dermatitis. Tildiem dosage: 60 Mg Qd Po. During the same period patient was treated with CLAVENTIN (1000 Mg Tid Iv) (View Claventin Review and Claventin Label ), FLAGYL /00012501/ (View Flagyl /00012501/ Review and Flagyl /00012501/ Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), NOVOMIX /01475801/ (View Novomix /01475801/ Review and Novomix /01475801/ Label ). Patient was hospitalized.

5255218-5 | Atrioventricular Block First Degree, Atrioventricular Block Second Degree, Bradyarrhythmia, Bradycardia, Electrocardiogram Qrs Complex Shortened, Intentional Overdose
Patient was taking Tildiem (View Usage). After Tildiem was administered, patient had the following side effects: atrioventricular block first degree, atrioventricular block second degree, bradyarrhythmia, bradycardia, electrocardiogram qrs complex shortened, intentional overdose on Feb 12, 2007 from FRANCE Additional patient health information: Male patient , 68 years of age, . Tildiem dosage: 300 Mg Once Po. During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), /01220701/ (View /01220701/ Review and /01220701/ Label ). Patient was hospitalized.

5019533-2 | Anorexia, Jaundice, Nausea
Adverse event was reported on May 12, 2006 by a Male patient taking Tildiem (View Usage) (Dosage: 200 Mg Q Day Po) was diagnosed with angina pectoris, acute coronary syndrome, blood cholesterol increased and. Location: UNITED KINGDOM , 53 years of age, Patient experienced the following unwanted or unexpected effects: anorexia, jaundice (What is jaundice?), nausea (What is nausea?). During the same period patient was treated with CLOPIDOGREL (75 Mg Q Day Po) (View Clopidogrel Review and Clopidogrel Label ), SIMVASTATIN (40 Mg Q Day Po) (View Simvastatin Review and Simvastatin Label ), GTN S (View Gtn-s Review and Gtn-s Label ), SERETIDE (View Seretide Review and Seretide Label ), IMDUR (View Imdur Review and Imdur Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

4920147-0 | Arthralgia, Musculoskeletal Stiffness
on Mar 04, 2005 Female patient from UNITED KINGDOM , 45 years of age, was diagnosed with aortic valve stenosis and was treated with Tildiem (View Usage). Patient had the following side effects: arthralgia, musculoskeletal stiffness. Tildiem dosage: 250 Mg Q Day, Po. During the same period patient was treated with DILTIAZEM (120 Mg Daily, Po) (View Diltiazem Review and Diltiazem Label ), PROPAIN (View Propain Review and Propain Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), CO PROXAMOL (View Co-proxamol Review and Co-proxamol Label ). Patient was hospitalized.

4654068-8 | Acute Myocardial Infarction, Cardiac Arrest
on Apr 19, 2005 Male patient from , 80 years of age, was treated with Tildiem (View Usage). After Tildiem was administered, patient had the following side effects: acute myocardial infarction, cardiac arrest (What is cardiac arrest?). Tildiem dosage: 300 Mg Q Day Po. During the same period patient was treated with SIMVASTATIN (10 Mg Q Day Po) (View Simvastatin Review and Simvastatin Label ).

4633215-8 | Rash Maculo-papular, Toxic Skin Eruption
Patient was taking Tildiem (View Usage). Patient experienced the following unwanted or unexpected effects: rash maculo-papular, toxic skin eruption on Mar 25, 2005 from Additional patient health information: Female patient , 47 years of age, was diagnosed with hypertension and. Tildiem dosage: Po. During the same period patient was treated with DECONTRACTYL (Po) (View Decontractyl Review and Decontractyl Label ), XANAX (View Xanax Review and Xanax Label ), CLARITYNE (View Clarityne Review and Clarityne Label ), SPASMINE JOLLY (View Spasmine Jolly Review and Spasmine Jolly Label ). Patient was hospitalized.

4630222-6 | Hepatic Fibrosis, Hepatic Steatosis
Adverse event was reported on Mar 22, 2005 by a Female patient taking Tildiem (View Usage) (Dosage: Df) was diagnosed with hypertension and. Location: , 63 years of age, Patient had the following side effects: hepatic fibrosis, hepatic steatosis.

4615206-6 | Arthralgia, Musculoskeletal Stiffness
on Mar 04, 2005 Female patient from , 45 years of age, was diagnosed with aortic stenosis and was treated with Tildiem (View Usage). After Tildiem was administered, patient had the following side effects: arthralgia, musculoskeletal stiffness. Tildiem dosage: 250 Mg Q Day Po. During the same period patient was treated with DILTIAZEM (120 Mg Daily Po) (View Diltiazem Review and Diltiazem Label ), PROPAIN (View Propain Review and Propain Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), CO PROXAMOL (View Co-proxamol Review and Co-proxamol Label ). Patient was hospitalized.

4609714-1 | Blood Chloride Decreased, Blood Glucose Increased, C-reactive Protein Increased, Condition Aggravated, Nephritis Interstitial, Pco2 Decreased, Renal Failure
on Feb 24, 2005 Female patient from , 57 years of age, was treated with Tildiem (View Usage). Patient experienced the following unwanted or unexpected effects: blood chloride decreased, blood glucose increased, c-reactive protein increased, condition aggravated, nephritis interstitial, pco2 decreased, renal failure. Tildiem dosage: 60 Mg Tid Po. During the same period patient was treated with TRIATEC (2.5 Mg 3xwk Po) (View Triatec Review and Triatec Label ), INDOCIN (25 Mg Q Day Po) (View Indocin Review and Indocin Label ), ARCALION (View Arcalion Review and Arcalion Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), ESBERIVEN (View Esberiven Review and Esberiven Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), INDOCOLLYRE (View Indocollyre Review and Indocollyre Label ). Patient was hospitalized.

4589700-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Patient was taking Tildiem (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased on Feb 01, 2005 from Additional patient health information: Female patient , 81 years of age, was diagnosed with tachycardia and. Tildiem dosage: 60 Mg Unk Po. During the same period patient was treated with CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), PREVISCAN (View Previscan Review and Previscan Label ), CORDARONE (View Cordarone Review and Cordarone Label ), LASILIX (View Lasilix Review and Lasilix Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ). Patient was hospitalized.

4576396-7 | Tendon Rupture
Adverse event was reported on Jan 20, 2005 by a Female patient taking Tildiem (View Usage) (Dosage: 120 Mg Q Day Po) was diagnosed with hypercholesterolaemia and. Location: , 69 years of age, After Tildiem was administered, patient had the following side effects: tendon rupture. During the same period patient was treated with COLCHICINE ^HOUDE^ (1 Mg Q Day Po) (View Colchicine ^houde^ Review and Colchicine ^houde^ Label ), KARDEGIC (160 Mg Q Day Po) (View Kardegic Review and Kardegic Label ), ROCALTROL (0.25 Mcg Q Day Po) (View Rocaltrol Review and Rocaltrol Label ), TAHOR (Df Po) (View Tahor Review and Tahor Label ). Patient was hospitalized.

4567990-8 | Blood Pressure Decreased, Circulatory Collapse, Heart Rate Decreased
on Jan 12, 2005 Female patient from , 72 years of age, was diagnosed with hypertension, myocardial infarction, blood pressure increased and was treated with Tildiem (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, circulatory collapse, heart rate decreased. Tildiem dosage: 400 Mg Q Day Po. During the same period patient was treated with METOPROLOL (100 Mg Bid Po) (View Metoprolol Review and Metoprolol Label ), SOLPADOL (View Solpadol Review and Solpadol Label ), QUININE SULPHATE (View Quinine Sulphate Review and Quinine Sulphate Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ). Patient was hospitalized.

4567989-1 | Acute Pulmonary Oedema, Atrioventricular Block Complete, Cardiac Arrest, Ventricular Fibrillation
on Jan 12, 2005 Female patient from , 75 years of age, was treated with Tildiem (View Usage). Patient had the following side effects: acute pulmonary oedema, atrioventricular block complete, cardiac arrest (What is cardiac arrest?), ventricular fibrillation. Tildiem dosage: 120 Mg Q Day Po. During the same period patient was treated with BISOPROLOL FUMARATE (5 Mg Q Day Po) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LENITRAL (View Lenitral Review and Lenitral Label ), RISORDAN (View Risordan Review and Risordan Label ). Patient was hospitalized.

4553277-6 | Aortic Stenosis, Atrial Fibrillation, Blood Ph Decreased, Blood Pressure Diastolic Decreased, Bradycardia, Cardiac Failure, Hepatic Pain, Left Ventricular Failure, Malaise
Patient was taking Tildiem (View Usage). After Tildiem was administered, patient had the following side effects: aortic stenosis, atrial fibrillation (What is atrial fibrillation?), blood ph decreased, blood pressure diastolic decreased, bradycardia, cardiac failure, hepatic pain, left ventricular failure, malaise on Jan 13, 2005 from Additional patient health information: Female patient , 90 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), atrial flutter and. Tildiem dosage: 60 Mg Q Day Po. During the same period patient was treated with HEMIGOXINE NATIVELLE (0.125 Mg Q Day Po) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), DOPERGINE (View Dopergine Review and Dopergine Label ), MODOPAR (View Modopar Review and Modopar Label ). Patient was hospitalized.